Presentation is loading. Please wait.

Presentation is loading. Please wait.

Death from thyroid cancer of follicular cell origin1

Published byLinette Rich Modified over 6 years ago

Similar presentations

Presentation on theme: "Death from thyroid cancer of follicular cell origin1"— Presentation transcript:

1 Death from thyroid cancer of follicular cell origin1
Hurng-Sheng Wu, MD, Michael T Young, Philip H.G Ituarte, Phd, mph, Alessandra D’Avanzo, MD, Quan-Yang Duh, md, Francis S Greenspan, MD, Keh Chuan Loh, MD, Orlo H Clark, md  Journal of the American College of Surgeons  Volume 191, Issue 6, Pages (December 2000) DOI: /S (00)

2 Figure 1 Kaplan-Meier cumulative probability of survival by age in 102 patients with differentiated thyroid cancer of follicular cell origin. Journal of the American College of Surgeons  , DOI: ( /S (00) )

3 Figure 2 Kaplan-Meier cumulative probability of survival by diagnosis.
Journal of the American College of Surgeons  , DOI: ( /S (00) )

4 Figure 3 Kaplan-Meier cumulative probability of survival by TNM stage.
Journal of the American College of Surgeons  , DOI: ( /S (00) )

5 Figure 4 Kaplan-Meier cumulative probability of survival by MACIS score. MACIS, metastases, age, completeness of resection, invasion, size. Journal of the American College of Surgeons  , DOI: ( /S (00) )

6 Figure 5 Kaplan-Meier cumulative probability of survival for persistent (6 months) versus recurrent disease. Journal of the American College of Surgeons  , DOI: ( /S (00) )

7 Figure 6 Kaplan-Meier cumulative probability of survival for recurrent thyroid cancer by local, regional, and distant metastases. Journal of the American College of Surgeons  , DOI: ( /S (00) )

Download ppt "Death from thyroid cancer of follicular cell origin1"

Similar presentations

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.

Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.
Volume 144, Issue 4, Pages (October 2013)

Volume 144, Issue 4, Pages (October 2013)
Volume 105, Issue 3, Pages (March 1994)

Volume 105, Issue 3, Pages (March 1994)
Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Volume 13, Issue 12, Pages (December 2012)

Volume 13, Issue 12, Pages (December 2012)
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Mitral stenosis with pulmonary hypertension: We should operate early

Mitral stenosis with pulmonary hypertension: We should operate early
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 
The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis  Annemarie T. Fernandes, BA, Eric.

The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis  Annemarie T. Fernandes, BA, Eric.
Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.

Similar presentations

Ads by Google